Pall Integrated Solutions for Gene Therapy


Pall have technologies that enable production of viral vectors on a production scale in a relatively small footprint. The statement holds true for both AAV and lent virus. The talk will cover both upstream and downstream technologies starting with seed train all the way through to the final formulation and filling step. With regards to bioreactors we will cover both adherent cell and suspension cell capabilities and projected future movements in the field. We will touch on process development services (PDS) where Pall are able to bring all of their expertise in continuous intensified process development to shorten the path to market for gene therapies.


Rick Morris, Ph.D.


Senior Vice President, R&D

Palll Biotech

Dr. Rick Morris has held many senior-level positions within both the Life Sciences and Industrial lines of business at Pall Corporation, gaining experience in the biopharmaceutical, medical, food & beverage and laboratory markets during his 30-year tenure. In September 2017, he was appointed as a senior vice president of R&D for Pall, which combines both single use technologies and biopharmaceutical groups, with a specific focus on the rapidly growing field of continuous bioprocessing. In this role Dr. Morris leads internal and external research and development projects on a global basis. He is based in Westborough, MA, USA and has R&D teams in the USA, UK and Belgium.

Pall Biotech Integrated Solutions for Gene Therapy

Scale Up And Risk Mitigation Of Therapeutic Viral Vectors For Gene Therapy

Register to learn more about scale up and risk mitigation of viral vectors for GT.

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
September 2021

New Product Launch: The Palltronic Flowstar V Instrument


Discover a new level in filter integrity testing as we introduce our newest instrument and show you how it meets the latest industry needs and regulations to be first choice in critical applications.


We’ve seen huge changes in the pharmaceutical industry since we introduced our first filter integrity test instruments in the 1980s.  Join us, as we jet set through the evolution of filter integrity testing and reveal our newest addition to the Palltronic family.


We will look at:

  • How UX (user experience) testing has made this our easiest and most intuitive system yet
  • Automation options for simplified PUPSIT and control of your process
  • Data integrity compliance to the highest standards.


Find out how the Palltronic Flowstar V instrument can be integrated seamlessly into your process and reduce operator time spent on filter testing.